Robert Shepler - Nov 18, 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Robert G. Shepler, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Nov 18, 2021
Transactions value $
$441,005
Form type
4
Date filed
11/18/2021, 08:08 PM
Previous filing
May 25, 2021
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Purchase $183K +15K $12.17 15K Nov 18, 2021 Direct F1
transaction AKYA Common Stock Purchase $259K +20K +133.33% $12.93 35K Nov 18, 2021 Direct F2
holding AKYA Common Stock 215K Nov 18, 2021 Robert G. Shepler Separate Property Trust of 2008
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $11.85-$12.75. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.
F2 Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.85-$13.00. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within the range set forth herein.